Viatris Inc (VTRS) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Total Assets Chart for Viatris Inc

Viatris Inc (VTRS) total assets for FY2025 were USD 37.2B, a -10.4% change from FY2024. Viatris Inc's total assets grew from USD 56.0M in 1985 to USD 37.2B in 2025 (66316.2% over 40 years). Total assets compound annual growth rate: 5-year CAGR of -9.6%, 10-year CAGR of 5.3%, 20-year CAGR of 16.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$18.64B
Implied Share Price
$16.23
Enterprise Value
$30.77B
Revenue (TTM)
$14.74B
EBITDA
$4.29B
Profit Margin
-2.79%
Trailing P/E
—
Forward P/E
6.49
Price/Book (MRQ)
1.31
Price/Sales (TTM)
1.26
EV/EBITDA
11.74
EV/Revenue
2.09
Dividend Yield
2.99%
Book Value
$12.59
Free Cash Flow (FY2025)
$1.94B
Free Cash Flow Yield
10.39%

Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.